Income Taxes - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Jan. 01, 2022
Operating Loss Carryforwards [Line Items]
Statutory tax rate	21.00%	21.00%	21.00%
Valuation allowance	$ 243,811,000	$ 130,569,000
Valuation allowance, increase (decrease), amount	113,200,000
Deferred tax assets, deferred expense, capitalized research and development costs increase (decrease)				$ 43,200,000
Interest and penalties accrued	0	$ 0
Unrecognized tax benefits that would impact effective tax rate, if recognized	0
United States
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	597,000,000
Net operating loss carryforwards, not subject to expiration	553,800,000
Net operating loss carryforwards, subject to expiration	$ 43,200,000
Research and development activities, amortized over period	5 years
Capitalized expenses, amortization period				5 years
United States | Research Tax Credit Carryforward
Operating Loss Carryforwards [Line Items]
Research and development tax credit carryforwards	$ 21,100,000
U.S. State
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	547,800,000
U.S. State | Research Tax Credit Carryforward
Operating Loss Carryforwards [Line Items]
Research and development tax credit carryforwards	3,900,000
Tax credit carryforward, subject to expiration	50,000.00
Tax credit carryforward, not subject to expiration	$ 4,300,000
Foreign Tax Authority
Operating Loss Carryforwards [Line Items]
Research and development activities, amortized over period	15 years
Capitalized expenses, amortization period				15 years